Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01616745
Other study ID # H-1103-057-355
Secondary ID
Status Recruiting
Phase N/A
First received March 25, 2012
Last updated June 11, 2012
Start date July 2011
Est. completion date February 2021

Study information

Verified date June 2012
Source Seoul National University Hospital
Contact Jae-Joon Yim, MD
Phone 82-2-2072-2059
Email yimjj@snu.ac.kr
Is FDA regulated No
Health authority South Korea: Korea Food and Drug Administration (KFDA)
Study type Observational

Clinical Trial Summary

The purpose of this study is to elucidate phenotypic, clinical, and genetic characteristics of Korean Nontuberculosis Mycobacteria (NTM) patients.


Description:

To elucidate phenotypic, clinical, and genetic characteristics of Korean NTM patients.

Especially, to compare body mass index, positive rate of IGRA, and CFTR mutation with general Korean population.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date February 2021
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Persons met diagnostic criteria of NTM lung disease by ATS/IDSA on 2007

Exclusion Criteria:

- Already on treatment for NTM lung disease

- Appropriate exclusion of other lung diagnosis

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of,